SurgOnc Today®

In this episode, join the SSO HPB disease site working group as they count down the final five studies in the 2025 HPB wrapped. This episode dives into some of the year's most practice-changing publications in HPB surgical oncology: the ROC'N'ROLL Trial, best practices neoadjuvant therapy for pancreas cancer, the PANDRA-II Trial, the use of SBRT for resectable pancreas cancer, and the PREHEP Trial. Hear our guests Dr. Colin Court and Dr. Winnie Lo as they review the studies and unpack what these findings mean for clinical practice.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Lily Owei and Dr. Heather Wachtel key principles regarding the understanding and management of adrenal incidentalomas, as reported in the article, "The Landmark Series: Evaluation and Management of Adrenal Incidentalomas."

Family planning and fertility preservation can pose challenges for trainees and new surgical oncology attendings. The SSO Fellows and Young Attendings Committee tackles these topics within a three-part podcast. On this episode of SurgOnc Today, hosts Dr. Danielle Graham and Dr. Paige Aiello discuss fertility preservation techniques and other considerations with reproductive endocrinologist Dr. Nicole Budrys and surgeons Dr. Alisa Blumenthaler and Dr. Jordan Jackson.

In this episode, join the SSO HPB disease site working group as they count down the first five studies in the 2025 HPB wrapped. This episode dives into some of the year's most practice-changing publications in HPB surgical oncology: the Preopanc-2 Trial, the Collision Trial, the Tesla trial, the use of Kras in ablation for Colorectal Liver Metastases, and the ENDURO Trial. Hear our guests Dr. Sandra DiBrito and Dr. Neha Lad as they review the studies and unpack what these findings mean for clinical practice.

In this episode, Dr. Jeffrey E. Gershenwald discusses the critical role surgical oncologists play in advancing evidence-based public policy. Using the FDA's black-box warning on indoor tanning for minors as a case study, Dr. Gershenwald highlights the science behind melanoma risk in adolescents and why advocacy is essential to protecting the next generation. Tune in to explore how policy action, prevention, and oncology expertise intersect, and why your voice as an SSO member matters beyond the operating room.